title: Reduction of myocardial infarction after emergency coronary artery bypass grafting for failed coronary angioplasty with use of a normothermic reperfusion cardioplegia protocol.
abstract: Emergency coronary artery bypass grafting is necessary in 2.7% to 13.5% of patients undergoing elective percutaneous transluminal coronary angioplasty. Myocardial infarction develops in 11% to 49% of these patients, with 18% to 46% of infarcts resulting in new Q waves. Since February 1987 a revised protocol for myocardial preservation has been used in 19 patients undergoing emergency bypass grafting for failed angioplasty. Cardioplegia is induced with a normothermic blood cardioplegic solution. Multiple maintenance doses of cold (4 degrees C) blood cardioplegic solution are then delivered through the aortic root and vein grafts. Before the aortic crossclamp is removed, normothermic reperfusion cardioplegic solution is delivered through the aortic root and vein grafts. This group was compared with all patients undergoing emergency bypass grafting for failed angioplasty before February 1987. These 45 patients received cold induction of cardioplegic solution, multiple maintenance doses of cold cardioplegic solution, and no reperfusion cardioplegic solution. The prevalence of myocardial infarction in the group receiving cold cardioplegic solution was 65% versus 26% in the group receiving normothermic cardioplegic solution (p less than 0.007). Multivariate analysis identified the use of the normothermic cardioplegia protocol (p less than 0.005), nontotal occlusion of the angioplasty vessel (p less than 0.03), and presence of collateral flow to the angioplasty vessel (p less than 0.04) as being independently associated with absence of myocardial infarction.
authors.affiliation: Department of Medicine, Georgetown University Hospital, Washington, D.C.
authors.forename: R K
authors.initials: RK
authors.lastname: Bottner
authors.forename: R B
authors.initials: RB
authors.lastname: Wallace
authors.forename: M S
authors.initials: MS
authors.lastname: Visner
authors.forename: K S
authors.initials: KS
authors.lastname: Stark
authors.forename: E
authors.initials: E
authors.lastname: Recientes
authors.forename: N M
authors.initials: NM
authors.lastname: Katz
authors.forename: R A
authors.initials: RA
authors.lastname: Hopkins
authors.forename: G A
authors.initials: GA
authors.lastname: Patrissi
authors.forename: K M
authors.initials: KM
authors.lastname: Kent
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D002314:Cardioplegic Solutions; D003080:Cold Temperature; D001026:Coronary Artery Bypass; D003402:Creatine Kinase / Q000032:analysis; D004562:Electrocardiography; D004630:Emergencies; D005260:Female; D006324:Heart Arrest, Induced / Q000379:methods*; D006801:Humans; D007527:Isoenzymes; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D012307:Risk Factors
chemical_list: D002314:Cardioplegic Solutions; D007527:Isoenzymes; D003402:Creatine Kinase